New technologies in endo-urology

Poster Session 74

  • Location:
    Room London (Hall B2, level 0)
  • Chairs:
     J.H. Hong, Seoul (KR)
     P.M. Kronenberg, Amadora (PT)
     E. Nemr, Beirut (LB)
  • Aims and objectives of this session

    During this session, several new technologies will be presented such as biodegradable ureteral stents, new grasp integrated flexible cystoscope, burst laser lithotripsy and 3D printing of renal tumours.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
* 938
Biodegradable drug-eluting stents: Targeting urothelial tumors of upper urinary tract

By: Barros A.1, Browne S.2, Oliveira C.3, Reis R.L.1, Duarte A.1, Healy K.4, Lima E.E.3

Institutes: 13b’s Research Group, Dept. of Polymer Engineering, Gmr, Portugal, 2Centre for Research in Medical Devices (CÚRAM), National University of Ireland Galway, Galway, Ireland, 3Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 4University of California, Dept. of Bioengineering, Berkeley, United States of America

* 939
The new grasp-integrated flexible cystoscope (FC) Isiris (Coloplast®) for double J (DJ) removal: Evaluation of image quality, flow and flexibility

By: Talso M., Servan P., Emiliani E., Orosa A., Baghdadi M., Barreiro A., Proietti S., Traxer O.

Institutes: Hôpital Tenon, Université Pierre et Marie Curie – Paris VI, Dept. of Urology, Paris, France

A multicentric evaluation of a new single use solution for ureteral stent removal

By: Traxer O.1, Giusti G.2, Patterson J.3, Palmero J.L.4, Straub M.5, De La Rosette J.6

Institutes: 1Tenon Hospital, Assitance Publique-Hopitaux De Paris. Pierre Et Marie Curie University, Paris 6, Dept. of Urology, Paris, France, 2Humanitas Clinical and Research Center, Dept. of Urology, Rozzano, Italy, 3Sheffield Teaching Hospitals NHS Foundation Trust, Dept. of Urology, Sheffield, United Kingdom, 4Hospital Universitario La Ribera, Dept. of Urology, Valencia, Spain, 5Klinikum Rechts Der Isar Der Technischen Universität München, Dept. of Urology, Munich, Germany, 6AMC University Hospital, Dept. of Urology, Amsterdam, The Netherlands

Burst laser lithotripsy – a novel lithotripsy mode

By: Kronenberg P.1, Traxer O.2

Institutes: 1Hospital Prof. Doutor Fernando Fonseca, Dept. of Urology, Amadora, Portugal, 2Université Paris 6 Pierre Et Marie Curie – Hôpital Tenon, Dept. of Urology, Paris, France

Stone retropulsion with the use of a recently introduced holmium laser system

By: Panagopoulos V.1, Kallidonis P.1, Amanatides L.2, Ioannou P.2, Spiliopoulos N.3, Koukiou G.3, Vasilas M.1, Kyriazis I.1, Kemal W.1, Liatsikos E.1

Institutes: 1University of Patras, Dept. of Urology, Patras, Greece, 2University of Patras, Dept. of Chemical Engineering, Patras, Greece, 3University of Patras, Dept. of Physics, Patras, Greece

Results from a comparative multicentric study of Xenx™, the latest ureteric occlusion device with guide-wire utility

By: Sanguedolce F.1, Montanari E.2, Alvarez-Maestro M.9, Macchione N.2, Hruby S.3, Papatsoris A.4, Kallidonis P.5, Villa L.6, Honeck P.7, Traxer O.6, Greco F.8

Institutes: 1King’s College Hospital, Dept. of Urology, London, United Kingdom, 2San Paolo Hospital, Dept. of Urology, Milan, Italy, 3Paracelsus Medical University, Dept. of Urology, Salzburg, Austria, 4Sismanoglio General Hospital, Dept. of Urology, Athens, Greece, 5Patras University Hospital, Dept. of Urology, Patras, Greece, 6Tenon University Hospital, Dept. of Urology, Paris, France, 7Sindelfingen-Böblingen University Hospital, Dept. of Urology, Sindelfingen-Böblingen, Germany, 8Romolo Hospital, Dept. of Urology, Rocca Di Neto, Italy, 9Hospital Universitario Infanta Sofia, Dept. of Urology, Madrid, Spain

A new gesture-controlled tool using three-dimensional reconstruction of renovascular-collecting system-tumor anatomy to assist navigation of kidney during “zero ischemia” minimally invasive nephron sparing surgery in high complex renal cancer

By: Dourado Meneses A.1, Aragao Rocha B.2, Tolstenko Nogueira A.3, Lima Mattos P.A.1, Madeira Campos R.S.4, Cardoso Guimaraes G.4, Zequi S.C.4

Institutes: 1Sao Marcos Hospital, Dept. of Urology, Teresina, Brazil, 2FCM-USP, Dept. of Radiology, Sao Paulo, Brazil, 3UFPI, Dept. of Computer Science, Teresina, Brazil, 4AC Camargo Cancer Center, Dept. of Urology, Sao Paulo, Brazil

* 945
Does 3D technology affect visual system?

By: Tasca A.1, Benedetto G.1, Nigro F.1, Scremin E.1, Bartolomei L.2, Minicucci N.3, Pisani S.4

Institutes: 1Sant Bortolo Hopital, Dept. of Urology, Vicenza, 2Sant Bortolo Hopital, Dept. of Neurology, Vicenza, 3Institute Neuroscience, CNR Padova, Padova, 4Optometric, Milano, Milano

3D printing of renal tumors for preoperative simulation

By: Von Rundstedt F-C., Scovell J.S., Agrawal S.A., Zaneveld J., Link R.E.

Institutes: Baylor College of Medicine, Dept. of Urology, Houston, United States of America

The use of portable video media versus standard verbal communication in the urological consent process: A randomised controlled clinical trial

By: Nalavenkata S.1, Winter M.2, Kam J.3, Hardy E.3, Handmer M.3, Ainsworth H.3, Lee D.3, Louie-Johnsun M.3

Institutes: 1Royal Prince Alfred Hospital, Dept. of Urology, Sydney, Australia, 2Royal North Shore Hospital, Dept. of Urology, Sydney, Australia, 3Gosford Hospital, Dept. of Urology, Gosford, Australia

Extracorporeal shock wave therapy for chronic prostatitis III-a-b

By: Kulchavenya E., Shevchenko S., Brizhatyuk E.

Institutes: Novosibirsk Research TB Institute, Medical University, Dept. of Urology, Novosibirsk, Russia

Late Breaking News: Phase I/II CANON study: Novel oncolytic immunotherapy for the treatment of Non-Muscle Invasive Bladder Cancer using intravesical CAVATAK (Coxsackievirus A21)
 H. Pandha, Guildford (GB)